NexturnBioscience Co. Ltd Cash Flow Quality Index
NexturnBioscience Co. Ltd cash flow quality index. NexturnBioscience Co. Ltd (089140) has a Cash Flow Quality Index of 11.02x as of September 2025. Operating cash flow of ₩4.51 Billion exceeds net income of ₩409.51 Million, indicating high earnings quality where cash backs reported profits. See NexturnBioscience Co. Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of NexturnBioscience Co. Ltd (2007–2023)
Cash flow quality index of NexturnBioscience Co. Ltd from 2007 to 2023. Historical Cash Flow Quality Index for NexturnBioscience Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore NexturnBioscience Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
NexturnBioscience Co. Ltd Cash Flow Quality Index by Year (2007–2023)
NexturnBioscience Co. Ltd cash flow quality index by year from 2007 to 2023. Year-by-year earnings quality comparison for NexturnBioscience Co. Ltd. For the full cash flow conversion analysis, see 089140 cash flow metrics.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.20x | ₩-1.97 Billion | ₩9.68 Billion | ▼ -142.8% |
| 2019 | 0.48x | ₩2.74 Billion | ₩5.76 Billion | ▼ -72.6% |
| 2018 | 1.73x | ₩9.63 Billion | ₩5.55 Billion | ▲ +131.4% |
| 2017 | 0.75x | ₩5.08 Billion | ₩6.78 Billion | ▼ -7.5% |
| 2016 | 0.81x | ₩17.88 Billion | ₩22.05 Billion | ▼ -42.4% |
| 2015 | 1.41x | ₩1.92 Billion | ₩1.36 Billion | ▼ -11.4% |
| 2014 | 1.59x | ₩6.48 Billion | ₩4.08 Billion | ▲ +1584.5% |
| 2010 | 0.09x | ₩235.94 Million | ₩2.50 Billion | ▼ -89.6% |
| 2009 | 0.91x | ₩998.03 Million | ₩1.10 Billion | ▲ +98.4% |
| 2008 | 0.46x | ₩945.34 Million | ₩2.06 Billion | ▼ -45.0% |
| 2007 | 0.83x | ₩2.26 Billion | ₩2.71 Billion | — |